Academic Position in Stroke Neurology (Stroke-Oncology Focus)

The Department of Clinical Neurosciences, in the Cumming School of Medicine, University of Calgary, invites applications for a Contingent Term appointment at the Assistant Professor level. This position will be under the Academic Medicine & Health Services Program (AMHSP), with a specialization in Stroke Neurology and a dedicated focus on stroke–oncology research and clinical care. The successful candidate will be appointed to the Division of Neurology.

The Department is seeking to recruit an academic clinician specializing in the intersection of stroke and cancer, including cancer-associated stroke, mechanisms of hypercoagulability, and translational and clinical research aimed at improving diagnosis, prevention, and treatment of cancer-related stroke.

The successful candidate will lead a comprehensive stroke–oncology research program that advances mechanistic understanding, diagnostic precision, and clinical management of stroke in patients with cancer. Expected areas of research focus include cancer-associated stroke and mechanisms of hypercoagulability; epidemiology and population-based prevention strategies for stroke in cancer; translational research in stroke oncology incorporating genomics, proteomics, biomarkers, and molecular signatures; advanced neuroimaging, AI-enabled analysis, and large-data approaches; clinical trials, registries, and real-world pragmatic evaluation in stroke–oncology; development of prediction tools, diagnostic algorithms, and risk-stratification models; and collaborative research initiatives involving oncology, hematology, radiology, and palliative medicine.

The candidate will be expected to contribute to undergraduate medical education, clerkship and postgraduate neurology training, and the mentorship of neurology residents, stroke fellows, oncology trainees, and graduate students. Additional educational responsibilities include participation in Neuroscience Grand Rounds, stroke rounds, and Continuing Medical Education activities.

Approximately 60–70% of effort will be protected for research within the AMHSP structure, with the remaining approximately 25% allocated to clinical and educational activities.